Lenvima is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lenvatinib.
| Product ID | 62856-712_0595269f-a64e-45c8-9490-4cecc2a06227 |
| NDC | 62856-712 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lenvima |
| Generic Name | Lenvatinib |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-08-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206947 |
| Labeler Name | Eisai Inc. |
| Substance Name | LENVATINIB |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2018-08-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA206947 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-08-15 |
| Marketing Category | NDA |
| Application Number | NDA206947 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-08-15 |
| Ingredient | Strength |
|---|---|
| LENVATINIB | 4 mg/1 |
| SPL SET ID: | f4bedd21-efde-44c6-9d9c-b48b78d7ed1e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62856-704 | Lenvima | Lenvatinib |
| 62856-708 | Lenvima | Lenvatinib |
| 62856-710 | Lenvima | Lenvatinib |
| 62856-712 | Lenvima | Lenvima |
| 62856-718 | Lenvima | Lenvima |
| 62856-720 | Lenvima | Lenvima |
| 62856-724 | Lenvima | Lenvima |
| 62856-714 | Lenvima | Lenvima |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LENVIMA 85778136 4744029 Live/Registered |
Eisai R&D Management Co., Ltd. 2012-11-13 |